SANOCHEMIA Pharmazeutika Overview

  • Founded
  • 1994
Founded
  • Status
  • Public
  • Employees
  • 120
Employees
  • Stock Symbol
  • SAC
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $0.07
  • (As of Friday Closing)

SANOCHEMIA Pharmazeutika General Information

Description

Sanochemia Pharmazeutika AG is a specialty pharmaceuticals company. It focused on the development and manufacture of novel drugs and diagnostics in selected indication areas which includes neurodegeneration, pain, and oncology, as well as diagnostics based on contrast media. The products of the company address the unmet medical need and offer the potential for significant returns. Its business divisions are Active pharmaceutical ingredients which are engaged in the development and production of new active pharmaceutical ingredients ranging from establishing laboratory processes through up-scaling to industrial-scale production; Pharmaceutical production which manufactures sterile and semi-sterile liquid presentations; Clinical Diagnostics and Veterinary Pharmaceuticals.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
DUS
Primary Office
  • Landeggerstrasse 7 and 33
  • Neufeld an der Leitha, Burgenland 2491
  • Austria
+43 02624 00000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SANOCHEMIA Pharmazeutika Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.07 $0.07 $0.04 - $2.27 $1.26M 15.6M 313.49 -$1.44

SANOCHEMIA Pharmazeutika Financials Summary

In Thousands,
USD
TTM 31-Mar-2019 FY 2018 30-Sep-2018 FY 2017 30-Sep-2017 FY 2016 30-Sep-2016
EV 44,570 42,047 42,136 35,066
Revenue 38,580 39,289 45,630 43,660
EBITDA (10,052) (6,244) 3,987 3,484
Net Income (19,048) (15,795) (278) (617)
Total Assets 77,278 79,545 88,261 87,147
Total Debt 19,271 20,731 18,453 20,712
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SANOCHEMIA Pharmazeutika Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SANOCHEMIA Pharmazeutika‘s full profile, request access.

Request a free trial

SANOCHEMIA Pharmazeutika Executive Team (3)

Name Title Board Seat Contact Info
Johann Roither Chief Executive Officer
Timo Bender Co-Managing Director
Thomas Erkinger Co-Managing Director
To view SANOCHEMIA Pharmazeutika’s complete executive team members history, request access »

SANOCHEMIA Pharmazeutika Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SANOCHEMIA Pharmazeutika Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SANOCHEMIA Pharmazeutika‘s full profile, request access.

Request a free trial

SANOCHEMIA Pharmazeutika Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 & 000000 21-Sep-2011 000000000000000000 00.000 Other Pharmaceuticals and Biotechnology
AlcaSynn Pharmaceuticals 09-Jun-2006 Merger/Acquisition 000.00 Drug Discovery
To view SANOCHEMIA Pharmazeutika’s complete acquisitions history, request access »

SANOCHEMIA Pharmazeutika Subsidiaries (1)

Company Name Industry Location Founded
0000000 & 000000 Other Pharmaceuticals and Biotechnology Vienna, Austria 0000
To view SANOCHEMIA Pharmazeutika’s complete subsidiaries history, request access »